Joseph Kim, MD

Professor and Chief of Surgical Oncology
Division of Surgical Oncology, Department of Surgery, University of Kentucky

Poster(s):

• E198: Analysis of Extracellular Vesicle Protein Profiles to Predict Treatment Response in a Phase II Clinical Trial with Cabozantinib and Pembrolizumab for Refractory Metastatic Pancreatic Cancer

• E202: The Association of Pre-Hepatic Artery Infusion Pump Systemic Chemotherapy with Intrahepatic Floxuridine Tolerance

• P48: Preliminary Analysis of a Phase II Randomized Comparison of Flat vs Weight-based Mitomycin C Intraperitoneal Chemotherapy